Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shankar J Chinta

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Free Radical Research|September 7, 2010
Nitrosylation and nitration of mitochondrial complex I in Parkinson's diseaseShankar J Chinta, Julie K Andersen
Free Radical Biology & Medicine|October 7, 2006
Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's diseaseShankar J Chinta, Julie K Andersen
Cell Cycle (Georgetown, Tex.)|December 14, 2011
Prospects and challenges for the use of stem cell technologies to develop novel therapies for Parkinson diseaseShankar J Chinta, Julie K Andersen
The International Journal of Biochemistry & Cell Biology|March 4, 2005
Dopaminergic neuronsShankar J Chinta, Julie K Andersen
Biochimica Et Biophysica Acta|March 25, 2008
Redox imbalance in Parkinson's diseaseShankar J Chinta, Julie K Andersen
Frontiers in Aging Neuroscience|June 3, 2022
Editorial: Role of Senescence in Neurodegenerative DiseasesFerit Tüzer, Shankar J Chinta, Tania Araujo Viel
CNS & Neurological Disorders Drug Targets|September 18, 2013
Pharmacological prolyl hydroxylase domain inhibition as a therapeutic target for Parkinson's diseaseSubramanian Rajagopalan, Shankar J Chinta, Julie K Andersen
Brain Research. Molecular Brain Research|April 29, 2005
Presence of splice variant forms of cytochrome P4502D1 in rat brain but not in liverShankar J Chinta, Harish V Pai, Vijayalakshmi Ravindranath
Journal of Neural Transmission (Vienna, Austria : 1996)|May 2, 2018
An inducible MAO-B mouse model of Parkinson's disease: a tool towards better understanding basic disease mechanisms and developing novel therapeuticsManish Chamoli, Shankar J Chinta, Julie K Andersen
Parkinson'S Disease|June 6, 2012
A possible novel anti-inflammatory mechanism for the pharmacological prolyl hydroxylase inhibitor 3,4-dihydroxybenzoate: implications for use as a therapeutic for Parkinson's diseaseShankar J Chinta, Subramanian Rajagopalan, Abirami Ganesan, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Free Radical Research|September 7, 2010
Nitrosylation and nitration of mitochondrial complex I in Parkinson's diseaseShankar J Chinta, Julie K Andersen
Free Radical Biology & Medicine|October 7, 2006
Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's diseaseShankar J Chinta, Julie K Andersen
Cell Cycle (Georgetown, Tex.)|December 14, 2011
Prospects and challenges for the use of stem cell technologies to develop novel therapies for Parkinson diseaseShankar J Chinta, Julie K Andersen
The International Journal of Biochemistry & Cell Biology|March 4, 2005
Dopaminergic neuronsShankar J Chinta, Julie K Andersen
Biochimica Et Biophysica Acta|March 25, 2008
Redox imbalance in Parkinson's diseaseShankar J Chinta, Julie K Andersen
Frontiers in Aging Neuroscience|June 3, 2022
Editorial: Role of Senescence in Neurodegenerative DiseasesFerit Tüzer, Shankar J Chinta, Tania Araujo Viel
CNS & Neurological Disorders Drug Targets|September 18, 2013
Pharmacological prolyl hydroxylase domain inhibition as a therapeutic target for Parkinson's diseaseSubramanian Rajagopalan, Shankar J Chinta, Julie K Andersen
Brain Research. Molecular Brain Research|April 29, 2005
Presence of splice variant forms of cytochrome P4502D1 in rat brain but not in liverShankar J Chinta, Harish V Pai, Vijayalakshmi Ravindranath
Journal of Neural Transmission (Vienna, Austria : 1996)|May 2, 2018
An inducible MAO-B mouse model of Parkinson's disease: a tool towards better understanding basic disease mechanisms and developing novel therapeuticsManish Chamoli, Shankar J Chinta, Julie K Andersen
Parkinson'S Disease|June 6, 2012
A possible novel anti-inflammatory mechanism for the pharmacological prolyl hydroxylase inhibitor 3,4-dihydroxybenzoate: implications for use as a therapeutic for Parkinson's diseaseShankar J Chinta, Subramanian Rajagopalan, Abirami Ganesan, et al.
Pageof 5